dbACP: A Comprehensive Database of Anti-Cancer Peptides

8 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp02202 C7A-Δ KILRGVAKKIMRTFLRRILTGKK NK-2 variants Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 7.5 ± 0.4 µM
dbacp02203 C7A-Δ KILRGVAKKIMRTFLRRILTGKK NK-2 variants Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 13.8 ± 2.0 µM
dbacp02204 C7A-Δ KILRGVAKKIMRTFLRRILTGKK NK-2 variants Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 9.3 ± 1.5 µM
dbacp02205 C7A-Δ KILRGVAKKIMRTFLRRILTGKK NK-2 variants Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 13.1 ± 0.9 µM
dbacp02206 C7A-Δ KILRGVAKKIMRTFLRRILTGKK Synthetic peptide Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 13.8 ± 2.0 µM
dbacp02207 C7A-Δ KILRGVAKKIMRTFLRRILTGKK Synthetic peptide Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 9.3 ± 1.5 µM
dbacp02208 C7A-Δ KILRGVAKKIMRTFLRRILTGKK Synthetic peptide Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 13.1 ± 0.9 µM
dbacp02222 C7A-Δ KILRGVAKKIMRTFLRRILTGKK Synthetic peptide Physical membrane disruption MTT/MTS assay E42/02 Skin cancer IC50 : 7.5 ± 0.4 µM